Lycium barbarum glycopeptide promotes neuroprotection in ET-1 mediated retinal ganglion cell degeneration
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Lycium barbarum glycopeptide promotes neuroprotection in ET-1 mediated retinal ganglion cell degeneration ; volume:22 ; number:1 ; day:5 ; month:8 ; year:2024 ; pages:1-15 ; date:12.2024
Journal of translational medicine ; 22, Heft 1 (5.8.2024), 1-15, 12.2024
- Urheber
-
Lakshmanan, Yamunadevi
Wong, Francisca Siu Yin
So, Kwok-Fai
Chan, Henry Ho-Lung
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-024-05526-8
- URN
-
urn:nbn:de:101:1-2410252115194.827242792063
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lakshmanan, Yamunadevi
- Wong, Francisca Siu Yin
- So, Kwok-Fai
- Chan, Henry Ho-Lung
- SpringerLink (Online service)
Ähnliche Objekte (12)
σ2R/TMEM97 in retinal ganglion cell degeneration
Molecular mechanisms mediating neuroprotection and axon regeneration in mature retinal ganglion cells
Neuroprotection and neuroregeneration of retinal ganglion cells after intravitreal carbon monoxide release
NFATc4 Knockout Promotes Neuroprotection and Retinal Ganglion Cell Regeneration After Optic Nerve Injury
Bax Contributes to Retinal Ganglion Cell Dendritic Degeneration During Glaucoma
APP upregulation contributes to retinal ganglion cell degeneration via JNK3
Pigment epithelium-derived factor mediates retinal ganglion cell neuroprotection by suppression of caspase-2
Intravitreal MPTP drives retinal ganglion cell loss with oral nicotinamide treatment providing robust neuroprotection
Neuroprotection by Wld S depends on retinal ganglion cell type and age in glaucoma
Brimonidine prevents axonal and somatic degeneration of retinal ganglion cell neurons
Extracellular vesicle encapsulated nicotinamide delivered via a trans-scleral route provides retinal ganglion cell neuroprotection
Involvement of endothelins in neuroprotection of valosin-containing protein modulators against retinal ganglion cell damage
σ2R/TMEM97 in retinal ganglion cell degeneration
Molecular mechanisms mediating neuroprotection and axon regeneration in mature retinal ganglion cells
Neuroprotection and neuroregeneration of retinal ganglion cells after intravitreal carbon monoxide release
NFATc4 Knockout Promotes Neuroprotection and Retinal Ganglion Cell Regeneration After Optic Nerve Injury
Bax Contributes to Retinal Ganglion Cell Dendritic Degeneration During Glaucoma
APP upregulation contributes to retinal ganglion cell degeneration via JNK3
Pigment epithelium-derived factor mediates retinal ganglion cell neuroprotection by suppression of caspase-2
Intravitreal MPTP drives retinal ganglion cell loss with oral nicotinamide treatment providing robust neuroprotection
Neuroprotection by Wld S depends on retinal ganglion cell type and age in glaucoma
Brimonidine prevents axonal and somatic degeneration of retinal ganglion cell neurons
Extracellular vesicle encapsulated nicotinamide delivered via a trans-scleral route provides retinal ganglion cell neuroprotection
Involvement of endothelins in neuroprotection of valosin-containing protein modulators against retinal ganglion cell damage
σ2R/TMEM97 in retinal ganglion cell degeneration
Molecular mechanisms mediating neuroprotection and axon regeneration in mature retinal ganglion cells
Neuroprotection and neuroregeneration of retinal ganglion cells after intravitreal carbon monoxide release
NFATc4 Knockout Promotes Neuroprotection and Retinal Ganglion Cell Regeneration After Optic Nerve Injury
Bax Contributes to Retinal Ganglion Cell Dendritic Degeneration During Glaucoma
APP upregulation contributes to retinal ganglion cell degeneration via JNK3
Pigment epithelium-derived factor mediates retinal ganglion cell neuroprotection by suppression of caspase-2
Intravitreal MPTP drives retinal ganglion cell loss with oral nicotinamide treatment providing robust neuroprotection
Neuroprotection by Wld S depends on retinal ganglion cell type and age in glaucoma
Brimonidine prevents axonal and somatic degeneration of retinal ganglion cell neurons
Extracellular vesicle encapsulated nicotinamide delivered via a trans-scleral route provides retinal ganglion cell neuroprotection